Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Minhua DENG"'
Autor:
Xin Chen, Baohong Jiang, Yu Gu, Zhaoyang Yue, Ying Liu, Zhiwei Lei, Ge Yang, Minhua Deng, Xuelong Zhang, Zhen Luo, Yongkui Li, Qiwei Zhang, Xuepei Zhang, Jianguo Wu, Chunyu Huang, Pan Pan, Fangjian Zhou, Ning Wang
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background SARS-CoV-2, a highly contagious coronavirus, is responsible for the global pandemic of COVID-19 in 2019. Currently, it remains uncertain whether SARS-CoV-2 possesses oncogenic or oncolytic potential in influencing tumor progressio
Externí odkaz:
https://doaj.org/article/030ede76d1cd43f0895bd51454f5ff2b
Autor:
Kang Ning, Yulu Peng, Yue Jiang, Zhen Li, Xin Luo, Lede Lin, Minhua Deng, Yi Wu, Tingxuan Huang, Yixin Huang, Ye Xie, Xiaofeng Yang, Manhuai Zhang, Longbin Xiong, Xiangpeng Zou, Zhaohui Zhou, Fangjian Zhou, Pei Dong, Chunping Yu, Zhiling Zhang
Publikováno v:
Biology of Sex Differences, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Background Although sex bias has been reported in the development and progression of renal cell carcinoma (RCC), the underlying mechanisms remain enigmatic. Here, we investigated the sex differences in the tumor microenvironment (TME) of RCC
Externí odkaz:
https://doaj.org/article/8ac0843d1ae5412fbf076fcd26e3e827
Autor:
Xianchong Zheng, Jiawei Chen, Minhua Deng, Kang Ning, Yulu Peng, Zhenhua Liu, Xiangdong Li, Zhaohui Zhou, Huancheng Tang, Yaoying Li, Tiebang Kang, Zhuowei Liu
Publikováno v:
Advanced Science, Vol 11, Iss 7, Pp n/a-n/a (2024)
Abstract Immune checkpoint inhibitors (ICIs) show promise as second‐line treatment for advanced bladder cancer (BLCA); however, their responsiveness is limited by the immune evasion mechanisms in tumor cells. This study conduct a Cox regression ana
Externí odkaz:
https://doaj.org/article/d8d86a1dbcd84ee1a823a671de24fae0
Autor:
Xing Hu, Hongliang Zeng, Yongbo Peng, Minhua Deng, Wei Xiang, Biao Liu, Jiahao Liu, Yunlong Fu, Zhiqiang Hu, Weibin Hou, Xuewen Liu, Jin Tang, Zhi Long, Long Wang, Jianye Liu
Publikováno v:
Small Science, Vol 3, Iss 12, Pp n/a-n/a (2023)
Due to the poor stability and adverse effects of chemotherapy drugs, such as gemcitabine, the current effectiveness of traditional chemotherapy is minimal. Some patients also show a low response rate to immunotherapy. Therefore, a novel material PD
Externí odkaz:
https://doaj.org/article/2fb9515b657841d2892e3529ecc6c869
Autor:
Wei Xiang, Yongbo Peng, Hongliang Zeng, Chunping Yu, Qun Zhang, Biao Liu, Jiahao Liu, Xing Hu, Wensu Wei, Minhua Deng, Ning Wang, Xuewen Liu, Jianfei Xie, Weibin Hou, Jin Tang, Zhi Long, Long Wang, Jianye Liu
Publikováno v:
Biomaterials Research, Vol 26, Iss 1, Pp 1-19 (2022)
Abstract Background Gemcitabine (GEM) is one of the first-line chemotherapies for bladder cancer (BC), but the GEMs cannot recognize cancer cells and have a low long-term response rate and high recurrence rate with side effects during the treatment o
Externí odkaz:
https://doaj.org/article/376519642c9f4585af9df1026e5b801b
Autor:
Zeshen Wu, Yulu Peng, Longbin Xiong, Jun Wang, Zhen Li, Kang Ning, Minhua Deng, Ning Wang, Wensu Wei, Zhiyong Li, Pei Dong, Chunping Yu, Fangjian Zhou, Zhiling Zhang
Publikováno v:
Cancer Medicine, Vol 11, Iss 19, Pp 3674-3686 (2022)
Abstract Sunitinib is one of the first‐line targeted drugs for metastatic renal cell carcinoma (RCC) with dual effects of antiangiogensis and proapoptosis. Sam68 (Src‐associated in mitosis, 68 KDa), is found being involved in cell apoptosis. This
Externí odkaz:
https://doaj.org/article/c2a28f99e24840dca26deb11cf889c05
Autor:
Zefu Liu, Xianchong Zheng, Jiawei Chen, Lisi Zheng, Zikun Ma, Lei Chen, Minhua Deng, Huancheng Tang, Liwen Zhou, Tiebang Kang, Yuanzhong Wu, Zhuowei Liu
Publikováno v:
Cell Reports, Vol 42, Iss 8, Pp 112963- (2023)
Summary: Dysregulation of transcription is a hallmark of cancer, including bladder cancer (BLCA). CRISPR-Cas9 screening using a lentivirus library with single guide RNAs (sgRNAs) targeting human transcription factors and chromatin modifiers is used t
Externí odkaz:
https://doaj.org/article/2eca148016f644c89ef0299cf07daf23
Autor:
Minhua Deng, Ning Wang, Zhiyong Li, Rixin Chen, Jinling Duan, Yulu Peng, Zeshen Wu, Zhiling Zhang, Lijuan Jiang, Xianchong Zheng, Dan Xie, Wensu Wei, Zhuowei Liu, Fangjian Zhou
Publikováno v:
Cell Death and Disease, Vol 13, Iss 2, Pp 1-14 (2022)
Abstract RNA-binding proteins (RBPs) are key regulators of gene expression. RBP dysregulation is reported to play essential roles in tumorigenesis. However, the role of RBPs in urothelial carcinoma of the bladder (UCB) is only starting to be unveiled
Externí odkaz:
https://doaj.org/article/7d76cfc727534944ae40969c5000ecb9
Autor:
Zhiyong Li, Lijuan Jiang, Zhiling Zhang, Minhua Deng, Wensu Wei, Huancheng Tang, Shengjie Guo, Yunlin Ye, Kai Yao, Zhuowei Liu, Fangjian Zhou
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 539-552 (2022)
Abstract Background Reliable molecular markers are much needed for early prediction of recurrence in muscle‐invasive bladder cancer (MIBC) patients. We aimed to build a long‐noncoding RNA (lncRNA) signature to improve recurrence prediction and ln
Externí odkaz:
https://doaj.org/article/e01bfefce61d45ff9b199c79c47b8b8d
Autor:
Mengqing Xiao, Jianye Liu, Liang Xiang, Kai Zhao, Dong He, Qinghai Zeng, Qun Zhang, Dan Xie, Minhua Deng, Yuxing Zhu, Yeyu Zhang, Yan Liu, Hao Bo, Xiaoming Liu, Xingyu Chen, Lian Gong, Ying Bao, Yi Hu, Yaxin Cheng, Liping Deng, Rongrong Zhu, Xiaowei Xing, Ming Zhou, Wei Xiong, Yanhong Zhou, Jianda Zhou, Xiaohui Li, Ke Cao
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 8, Pp n/a-n/a (2020)
Abstract Long noncoding RNAs (lncRNAs) play a crucial role in progression of bladder urothelial carcinoma (BUC). However, the molecular mechanisms behind this role have not been elucidated yet. Here, we found that the lncRNA MAFG‐AS1, which is high
Externí odkaz:
https://doaj.org/article/960b240de26146a1b4847c34545918bd